| The Eclectic (OLI) Paradigm of International Production: Past, Present and Future | 2001/07/01 | English | 554 |
| Owner as Manager, Extended Horizons and the Family Firm | 1999/02/01 | English | 541 |
| On Nudging: A Review ofNudge: Improving Decisions About Health, Wealth and Happinessby Richard H. Thaler and Cass R. Sunstein | 2009/11/01 | English | 395 |
| Industry Effects on the Determinants of Unquoted SMEs' Capital Structure | 2000/11/01 | English | 223 |
| Linking Innovation and Firm Performance: A New Approach | 2001/11/01 | English | 213 |
| The Role of Location in Competition | 1994/01/01 | English | 148 |
| Does Size Matter in Firm Performance? Evidence from US Public Firms | 2009/07/01 | English | 147 |
| The Importance of Sectoral Differences in the Application of Complementary HRM Practices for Innovation Performance | 2002/02/01 | English | 94 |
| The Eclectic Paradigm in the Global Economy | 2001/07/01 | English | 91 |
| Uncertainty of Outcome or Star Quality? Television Audience Demand for English Premier League Football | 2015/03/16 | English | 91 |
| The Wage and Employment Effects of Leveraged Buyouts in the UK | 2007/05/30 | English | 89 |
| Co–evolution of Industry Structure, Technology and Supporting Institutions, and the Making of Comparative Advantage | 1995/07/01 | English | 89 |
| Technological Convergence in the IT Industry: The Role of Strategic Technology Alliances and Technological Competencies | 1998/11/01 | English | 88 |
| The Diffusion of Process Innovations: A Selective Review | 1999/02/01 | English | 86 |
| The Effects of Market Concentration and Horizontal Mergers on Hospital Costs and Prices | 1998/07/01 | English | 85 |
| Generic Competition in the US Pharmaceutical Industry | 2006/02/01 | English | 81 |
| Competitive Tendering and Contracting in the Public Sector: A Survey | 1994/01/01 | English | 79 |
| The Legal Nature of the Firm and the Myth of the Firm-Market Hybrid | 2002/02/01 | English | 76 |
| Towards Reconciling Transaction Cost Economics and the Knowledge-based View of the Firm: The Context of Interfirm Collaborations | 2002/02/01 | English | 72 |
| Sabotage in Corporate Contests – An Experimental Analysis | 2007/11/01 | English | 72 |
| How to Measure and Draw Causal Inferences with Patent Scope | 2019/01/02 | English | 70 |
| The Dynamics of Motivation in New Organizational Forms | 2002/02/01 | English | 68 |
| Covid-19 Lockdown Cost/Benefits: A Critical Assessment of the Literature | 2021/09/29 | English | 65 |
| Foreign Direct Investment, Transactions Linkages, and the Performance of the Domestic Sector | 2002/11/01 | English | 64 |
| Brand Loyalty, Generic Entry and Price Competition in Pharmaceuticals in the Quarter Century after the 1984 Waxman-Hatch Legislation | 2011/07/01 | English | 63 |
| Price Discrimination for Pharmaceuticals: Welfare Effects in the US and the EU | 1997/11/01 | English | 58 |
| The Effect of Board Size and Composition on the Efficiency of UK Banks | 2011/11/01 | English | 56 |
| Levels of efficiency in UK retail banks: a DEA window analysis | 2003/11/01 | English | 55 |
| Internal Versus External R&D: A Study of R&D Choice with Sample Selection | 2002/07/01 | English | 54 |
| Foreign Ownership and Performance: Evidence from Italian Firms | 2017/08/01 | English | 51 |